Eukaryotic cells produce extracellular vesicles (EVs) mediating intercellular communication.
These vesicles encompass many bio-molecules such as proteins, nucleic acids, and lipids …

ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

Abstract Approximately, 1.4 million virus-induced cancers occur annually, representing
roughly 10% of the worldwide cancer burden, with the majority (> 85%) occurring in the …

Purpose: Use of circulating tumor DNA (ctDNA) for diagnosis is limited regarding the low
number of target molecules in early-stage tumors. Human papillomavirus (HPV)–associated …

In humans, retroviruses thrive more as symbionts than as parasites. Apart from the only two
modern exogenous human retroviruses (human T-cell lymphotropic and immunodeficiency …

HTLV-1 is a global infection with 5-20 million infected individuals. Although only a minority of
infected individuals develop myelopathy, lymphoproliferative malignancy, or inflammatory …

Human T cell leukemia virus 1 (HTLV-1) causes the functionally debilitating disease HTLV-1–
associated myelopathy/tropical spastic paraparesis (HAM/TSP) as well as adult T cell …

Human T‐cell leukemia virus type 1 (HTLV‐1) was discovered in the 1980s, but it is
estimated to have been infecting humans for more than ten thousand years. 1 With over 90 …

HTLV-1 is a retrovirus which causes diverse diseases in 10% of its infected population,
significantly worsening their quality of life and mortality rate. Even though it is globally …

Oncoviruses are viruses that can cause tumors. Seven viruses are currently recognized as
oncogenic in humans: Epstein Barr virus (EBV), Kaposi sarcoma-associated herpesvirus …